1428 related articles for article (PubMed ID: 16772865)
21. Substance abuse in schizophrenia: a review.
Buckley PF
J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
[TBL] [Abstract][Full Text] [Related]
22. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
Volavka J
J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
[TBL] [Abstract][Full Text] [Related]
23. Relapse prevention and recovery in the treatment of schizophrenia.
Schooler NR
J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
[TBL] [Abstract][Full Text] [Related]
24. New antipsychotic agents: emerging clinical profiles.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 1():12-7; discussion 28-30. PubMed ID: 10037165
[TBL] [Abstract][Full Text] [Related]
25. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.
Kim JH; Kim D; Park SH; Lee HB; Chung EK
J Nerv Ment Dis; 2007 Jul; 195(7):622-4. PubMed ID: 17632255
[TBL] [Abstract][Full Text] [Related]
26. Strategies for dosing and switching antipsychotics for optimal clinical management.
Buckley PF; Correll CU
J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
[TBL] [Abstract][Full Text] [Related]
27. Treatment adherence in schizophrenia and schizoaffective disorder.
Goff DC; Hill M; Freudenreich O
J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
[TBL] [Abstract][Full Text] [Related]
28. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
Misdrahi D; Llorca PM; Lançon C; Bayle FJ
Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in concomitant medication with benzodiazepines or antidepressants in first-break schizophrenic patients treated with antipsychotic medication.
Rijcken CA; Knegtering H; Bruggeman R; Tobi H; de Jong-van den Berg LT
Psychiatry Res; 2005 Apr; 134(2):143-50. PubMed ID: 15840415
[TBL] [Abstract][Full Text] [Related]
30. Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia.
Olfson M; Marcus SC; Wilk J; West JC
Psychiatr Serv; 2006 Feb; 57(2):205-11. PubMed ID: 16452697
[TBL] [Abstract][Full Text] [Related]
31. [What information do patients with schizophrenia have about their illness and treatment?].
Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
[TBL] [Abstract][Full Text] [Related]
32. Major depression and comorbid substance use disorders.
Davis L; Uezato A; Newell JM; Frazier E
Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
[TBL] [Abstract][Full Text] [Related]
33. What is the schizophrenic patients' level of information about their disease and their treatment?
Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
Encephale; 2000 Oct; 26 Spec No 1():15-22. PubMed ID: 11294058
[TBL] [Abstract][Full Text] [Related]
34. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
[TBL] [Abstract][Full Text] [Related]
35. A pilot study of barriers to medication adherence in schizophrenia.
Hudson TJ; Owen RR; Thrush CR; Han X; Pyne JM; Thapa P; Sullivan G
J Clin Psychiatry; 2004 Feb; 65(2):211-6. PubMed ID: 15003075
[TBL] [Abstract][Full Text] [Related]
36. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results.
Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
Psychiatr Danub; 2007 Jun; 19(1-2):10-9. PubMed ID: 17603411
[TBL] [Abstract][Full Text] [Related]
37. [Treatment adherence in schizophrenia. A comparison between patient's, relative's and psychiatrist's opinions].
Giner J; Cañas F; Olivares JM; Rodriguez A; Burón JA; Rodríguez-Morales A; Roca M
Actas Esp Psiquiatr; 2006; 34(6):386-92. PubMed ID: 17117335
[TBL] [Abstract][Full Text] [Related]
38. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
39. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.
Cleghorn JM; Kaplan RD; Szechtman B; Szechtman H; Brown GM; Franco S
J Clin Psychiatry; 1991 Jan; 52(1):26-30. PubMed ID: 1671032
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
